Aileron Therapeutics Inc.

NASDAQ: ALRN · Real-Time Price · USD
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 10:00 PM

Aileron Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.66 -0.89 -0.4 -1.94
PEG Ratio
-0.25 0.02 -0.15 0.04
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.76 2.04 0.58 1.14
P/FCF Ratio
-1.85 -0.71 -0.43 -2.09
P/OCF Ratio
-1.85 -0.71 -0.43 -2.1
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a 0.01 0.00 0.00
Quick Ratio
2.38 4.17 6.46 10.69
Current Ratio
2.38 4.17 6.46 10.69
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-1.16 -2.28 -1.45 -0.59
Return on Assets
-1.01 -0.15 -1.23 -0.53
Return on Invested Capital
-1.15 -0.16 -1.46 -0.59
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a